Literature DB >> 9428381

Phase II trial of navelbine and fluorouracil as second-line chemotherapy in metastatic breast carcinoma.

M E Froudarakis, G Catimel, J P Guastalla, P Rebattu, M Clavel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9428381     DOI: 10.1159/000011840

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  2 in total

1.  Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure.

Authors:  J Bonneterre; H Roché; A Monnier; J P Guastalla; M Namer; P Fargeot; S Assadourian
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

2.  Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane.

Authors:  Jin-Hee Ahn; Sung-Bae Kim; Tae-Won Kim; Sei-Hyun Ahn; Sun-Mi Kim; Jeong-Mi Park; Jung-Shin Lee; Yoon-Koo Kang; Woo Kun Kim
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.